Breast Cancer Incidence Dialed Down in Individuals With Low Genetic Risk

A team from the California-based population genomics firm Helix, Renown Health, and the University of Nevada School of Medicine has demonstrated the potential for delayed mammography-based screening in women with lower-than-usual breast cancer risk based on pathogenic variant and polygenic risk score (PRS) data.